COMPARISON OF THE ACTIVITY OF MEROPENEM WITH THAT OF OTHER AGENTS IN THE TREATMENT OF INTRAABDOMINAL, OBSTETRIC GYNECOLOGIC, AND SKIN AND SOFT-TISSUE INFECTIONS

被引:7
作者
PITKIN, D
SHEIKH, W
WILSON, S
HEMSELL, D
NICHOLS, R
NADLER, H
DOWZICKY, M
机构
[1] UNIV CALIF IRVINE,IRVINE MED CTR,ORANGE,CA 92668
[2] UNIV TEXAS,DALLAS,TX 75230
[3] TULANE UNIV,SCH MED,NEW ORLEANS,LA 70112
[4] RHONE POULENC RORER,COLLEGEVILLE,PA
关键词
D O I
10.1093/clinids/20.Supplement_2.S372
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Meropenem, a new carbapenem with improved stability in the presence of human dehydropeptidase-I [1], was evaluated in three prospective, multicenter, randomized, controlled clinical trials in North America. We compared the in vitro activity of meropenem and conventional antimicrobial agents for the treatment of intraabdominal, obstetric/gynecologic, and skin or soft tissue infections as well as the responses of pathogens to all of these agents. The trials of the drug for intraabdominal infection were double blind, and those for the obstetric/gynecologic and soft tissue infections were open labeled. Overall, MICs of meropenem for pathogens were lower, and the pathogen response rates were at least comparable to those for the following comparative agents: clindamycin plus tobramycin (for intraabdominal infections); clindamycin plus gentamicin (for obstetric/gynecologic infections); and imipenem and cilastatin (for skin or soft tissue infections). Meropenem has high in vitro potency and covers a broad spectrum of anaerobic and aerobic pathogens.
引用
收藏
页码:S372 / S375
页数:4
相关论文
共 5 条
[1]   STABILITY OF MEROPENEM AND EFFECT OF 1-BETA-METHYL SUBSTITUTION ON ITS STABILITY IN THE PRESENCE OF RENAL DEHYDROPEPTIDASE-I [J].
FUKASAWA, M ;
SUMITA, Y ;
HARABE, ET ;
TANIO, T ;
NOUDA, H ;
KOHZUKI, T ;
OKUDA, T ;
MATSUMURA, H ;
SUNAGAWA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1577-1579
[2]   EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF INTRAABDOMINAL INFECTIONS [J].
SOLOMKIN, JS ;
HEMSELL, DL ;
SWEET, R ;
TALLY, F ;
BARTLETT, J .
CLINICAL INFECTIOUS DISEASES, 1992, 15 :S33-S42
[3]  
1990, NCCLS M7T2 NAT COMM
[4]  
1993, NCCLS M11A3 NAT COMM
[5]  
1990, NCCLS M11A2 NAT COMM